Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-010456)

Filing Details

Accession Number:: 0000899243-20-010456
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-04-07 18:49:32
Reporting Period:: 2020-04-03

Accepted Time:: 2020-04-07 18:49:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1403752	Zymeworks Inc.	ZYME	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1761853	Ali Tehrani	C/O Zymeworks Inc. 1385 West 8Th Avenue, Suite 540 Vancouver A1 V6H 3V9	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2020-04-03	495	$33.39	59,781	No	4	P	Indirect	Held by spouse
Common Shares	Acquisiton	2020-04-03	80	$33.39	59,861	No	4	P	Indirect	Held by spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held by spouse
No	4	P	Indirect	Held by spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	256,009	Direct

Footnotes

The shares were purchased in multiple transactions and the price reported is a weighted average. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price.